CoChat

Considerations in the Design of Clinical Trials to Test Novel Entomological Approaches to Dengue Control

Open access
Wolbers, Marcel, Kleinschmidt, Immo, Simmons, Cameron P., Donnelly, Christl A. · 2012 · PLoS Neglected Tropical Diseases

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Dengue is the most important arboviral infection of humans. In endemic countries the scale of the dengue disease burden imparts an economic cost [1] and strains fragile health care systems. There are no licensed vaccines for prevention of dengue, and the public health response in endemic countries relies mostly on combating the principal mosquito vector, Aedes aegypti, via insecticides and breeding site removal. The sustained transmission of dengue in endemic settings together with its increasing global footprint indicates existing disease control strategies have been unsuccessful [2]. Novel vector control approaches to limit dengue virus (DENV) transmission include release of Ae. aegypti that carry transgenes that result in highly penetrant, dominant, late-acting, female-specific lethality [3]. In field cage experiments, the release of such mosquitoes in sufficient numbers results in eradication of the mosquito population [4]. Another strategy involves embryonic introduction of the obligate intracellular insect bacterium, Wolbachia, into strains of Ae. aegypti [5]. Strikingly, Wolbachia-infected Ae. aegypti are partially resistant to infection with DENV [6], and by virtue of the intrinsic capacity of some strains of Wolbachia to invade insect populations [6], [7], there is the prospect of achieving widespread biological resistance to DENV amongst Ae. aegypti populations. The life-shortening impact of some Wolbachia strains could also contribute to reductions in disease transmission [5]. The first entomological field trials of mosquitoes infected with Wolbachia (wMel and wMelPop strains) have now been successfully carried out in Cairns, Australia and have demonstrated that Wolbachia can establish itself at very high prevalence in field populations of Ae. aegypti [7]. However, the prospects of demonstrating reduction in DENV transmission in Cairns are slim given the episodic, imported nature of dengue outbreaks in this region. A critical challenge for all entomological approaches to control of vector-borne disease is how best to demonstrate efficacy in reducing disease transmission [8]. In principal, the high force of infection in dengue endemic countries should assist an evidence-gathering approach to this challenge. However, a feature of dengue epidemiology is that it is spatially and temporally heterogeneous [9]–[11]. Thus oscillations in disease incidence over time are common for a given region of transmission, and within each region it is common for focal “hot spots” of transmission to exist [3]. This heterogeneity in transmission means that uncontrolled observational studies of dengue transmission in a community where, for example, Wolbachia-infected Ae. aegypti have been released could take many years or decades to yield evidence that is suggestive of a benefit. Equally, the heterogeneity of dengue transmission poses challenges to traditional clinical trial approaches, as does the non-stationary nature of mosquito populations [8]. Here we review design and statistical considerations relevant to the conduct of clinical trials of these novel interventions and the practical challenges posed by the epidemiology of dengue in endemic settings. Whilst our discussion of trial design is focused on Wolbachia-infected Ae. aegypti, it is also relevant to other vector control interventions, such as genetically engineered male mosquitoes carrying a dominant lethal gene [4], insecticide-impregnated nets [12], or larvacides [13].

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pntd.0001937

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Sample size estimates for a PCRT or a SWCRT. Total number of clusters required for a PCRT (black lines) or a SWCRT (blue lines) depending on the size of the intervention effect. Solid lines correspond to 90% power, dashed lines to 80% power. Simulations are based on parameters determined from the Kamphaeng Phet dengue cohort (Thailand) (described in [10]) with three time periods each of 1-year duration, a surveillance cohort of 100 children in each cluster, and a two-sided significance level of 5%.
Figure 1 Sample size estimates for a PCRT or a SWCRT. Total number of clusters required for a PCRT (black lines) or a SWCRT (blue lines) depending on the size of the intervention effect. Solid lines correspond to 90% power, dashed lines to 80% power. Simulations are based on parameters determined from the Kamphaeng Phet dengue cohort (Thailand) (described in [10]) with three time periods each of 1-year duration, a surveillance cohort of 100 children in each cluster, and a two-sided significance level of 5%.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 41

Metadata

Authors
Wolbers, M., Kleinschmidt, I., Simmons, C. P., & Donnelly, C. A.
Affiliations
  • University of Oxford (GB)
  • London School of Hygiene & Tropical Medicine (GB)
  • Imperial College London (GB)
Corresponding author
Simmons, Cameron P.
Venue
PLoS Neglected Tropical Diseases
Published
2012-11-29
Volume
6
Issue
11
Pages
e1937
ISSN
  • 1935-2727 (ISSN-L)
  • 1935-2735
OpenAlex
W2117855998
Cited by
40
References
16
Citations by year
2025: 2 · 2024: 4 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 5 · 2017: 2 · 2016: 7 · 2015: 5 · 2014: 5 · 2013: 1
FWCI
3.40
Type
journal article
Language
en
Open access
Locations
  • PLoS neglected tropical diseases (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Spiral (Imperial College London) (submittedVersion, other-oa)
  • Greater South Information System
Funders
  • Foundation for the National Institutes of Health
  • Bill and Melinda Gates Foundation
  • Wellcome Trust (089276)
  • National Institutes of Health
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Mosquito-borne diseases and control
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Dengue and Mosquito Control Research
  • Life Sciences › Agricultural and Biological Sciences › Insect Science › Insect symbiosis and bacterial influences
Keywords
dengue control, Aedes aegypti, Wolbachia, dengue vector control, transgenic mosquitoes, dengue transmission, clinical trial design, transmission heterogeneity, dengue incidence, dengue serotypes, dengue vaccine
MeSH terms
Adult, Child, Child, Preschool, Clinical Trials as Topic, Dengue, Epidemiologic Methods, Humans, Mosquito Control, Research Design

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Considerations in the Design of Clinical Trials to Test Novel Entomological Approaches to Dengue Control. https://app.cochat.ai/papers/10.1371/journal.pntd.0001937
The paper
Wolbers, M., Kleinschmidt, I., Simmons, C. P., & Donnelly, C. A. (2012). Considerations in the Design of Clinical Trials to Test Novel Entomological Approaches to Dengue Control. PLoS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0001937

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.